Evidence map›Paper›PMID 20221250›Full record

ArticlePLoS genetics2010

Papillorenal syndrome-causing missense mutations in PAX2/Pax2 result in hypomorphic alleles in mouse and human.

Ramakrishna P Alur, Camasamudram Vijayasarathy, Jacob D Brown, Mohit Mehtani, Ighovie F Onojafe, Yuri V Sergeev, Elangovan Boobalan, Marypat Jones, Ke Tang, Haiquan Liu and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Mice with aAmerican journal of physiology. Renal physiology · 2024
    Article
  3. Improving Molecular Therapy in the Kidney.Molecular diagnosis & therapy · 2020
    Review
  4. Article
  5. Article
  6. Review
  7. Three NewNeuro-ophthalmology (Aeolus Press) · 2017
    Article
  8. Article
  9. Mutations in PAX2 associate with adult-onset FSGS.Journal of the American Society of Nephrology : JASN · 2014
    Article
  10. Article
  11. Article
  12. Renal coloboma syndrome.European journal of human genetics : EJHG · 2011
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Ramakrishna P AlurOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, United States of America.
Camasamudram Vijayasarathy
Jacob D Brown
Mohit Mehtani
Ighovie F Onojafe
Yuri V Sergeev
Elangovan Boobalan
Marypat Jones
Ke Tang
Haiquan Liu
Chun-Hong Xia
Xiaohua Gong
Brian P Brooks
National Eye Institute · USUniversity of California, Berkeley · USGeorgetown University · USNational Institutes of Health · USBaylor College of Medicine · USNational Human Genome Research Institute · USNational Institute on Deafness and Other Communication Disorders · US

Funding

The Genetics of Uveal ColobomaZIAEY000469 · NEI · NATIONAL EYE INSTITUTE · PI BROOKS, BRIAN · 2009 to 2025
$35.2M
Proteins From Hereditary Eye Diseases: In-silico and Experimental StudiesZIAEY000476 · NEI · NATIONAL EYE INSTITUTE · PI SERGEEV, YURI · 2009 to 2025
$16.8M
Cataracts, Connexin Mutants and Genetic ModifiersR01EY013849 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI Xiaohua Gong · 2002 to 2026
$8.2M
Intramural NIH HHSNEI NIH HHS EY013849NEI NIH HHS R01 EY013849
6 · The paper itself

Abstract

Papillorenal syndrome (PRS, also known as renal-coloboma syndrome) is an autosomal dominant disease characterized by potentially-blinding congenital optic nerve excavation and congenital kidney abnormalities. Many patients with PRS have mutations in the paired box transcription factor gene, PAX2. Although most mutations in PAX2 are predicted to result in complete loss of one allele's function, three missense mutations have been reported, raising the possibility that more subtle alterations in PAX2 function may be disease-causing. To date, the molecular behaviors of these mutations have not been explored. We describe a novel mouse model of PRS due to a missense mutation in a highly-conserved threonine residue in the paired domain of Pax2 (p.T74A) that recapitulates the ocular and kidney findings of patients. This mutation is in the Pax2 paired domain at the same location as two human missense mutations. We show that all three missense mutations disrupt potentially critical hydrogen bonds in atomic models and result in reduced Pax2 transactivation, but do not affect nuclear localization, steady state mRNA levels, or the ability of Pax2 to bind its DNA consensus sequence. Moreover, these mutations show reduced steady-state levels of Pax2 protein in vitro and (for p.T74A) in vivo, likely by reducing protein stability. These results suggest that hypomorphic alleles of PAX2/Pax2 can lead to significant disease in humans and mice.

Indexed as

AllelesAbnormalities, MultipleAmino Acid SequenceAnimalsCell LineCerebellumDNAEmbryo, MammalianEyeGene Expression Regulation, DevelopmentalHumansKidneyMaleMiceMice, Inbred C57BLMice, Mutant StrainsDNAMutant ProteinsPAX2 Transcription FactorRNA, Messenger

Identifiers

PMID20221250
PMCPMC2832668
OpenAlexW2050762231

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.